
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Tenascin-R CRISPR/Cas9 KO Plasmid (m) | sc-423465 | 20 µg | $397.00 |
Tnr encodes Tenascin-R, an extracellular matrix glycoprotein enriched in the central nervous system that modulates cell–cell and cell–matrix interactions during neural development and circuit maturation. Tenascin-R contributes to neurite outgrowth, axon guidance, synaptic stabilization, and myelination, in part through interactions with adhesion molecules and proteoglycans that shape the perineuronal net. By influencing extracellular signaling and structural plasticity, it impacts processes such as neuronal connectivity and activity-dependent remodeling. Altered Tenascin-R function or expression has been associated with neurodevelopmental and neuropsychiatric phenotypes, making it relevant for studying mechanisms underlying synaptic organization and network excitability in mouse models.
Tenascin-R CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Tnr gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Tnr together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Tnr open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Tenascin-R protein expression.
This CRISPR knockout system enables efficient generation of Tnr-deficient cell models for investigation of Tenascin-R signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.